ClinConnect ClinConnect Logo
Search / Trial NCT00482456

Homocysteine After Nitrous Oxide Anesthesia

Launched by MEDICAL UNIVERSITY OF VIENNA · Jun 1, 2007

Trial Information

Current as of May 06, 2025

Completed

Keywords

Nitrous Oxide Homocysteine Folate Vitamin B12

ClinConnect Summary

Nitrous oxide - laughing gas - is a widely used anaesthetic gas with many favourable but also some dangerous properties. Among the latter is the increase in homocysteine levels after nitrous oxide (N2O) exposure by inhibition of enzymes in the vitamin B12 pathway. Elevated homocysteine levels have been found to be an independent risk factor for ischemic events and are associated with an increased risk for perioperative myocardial ischemia. If a patient carries one or more loss-of-function mutations in enzymes of the methionine/homocysteine/folate pathway he is at an increased risk for hyper...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient scheduled for general anaesthesia (\> 2 hours)
  • Age \> 18 years
  • ASA status I-II
  • Exclusion Criteria:
  • Pregnancy
  • Age \< 18 years
  • contraindication against N2O: pneumothorax, mechanical bowel obstruction, middle ear occlusion, laparoscopic surgery
  • recent use of vitamin preps (B12, B6, folate)

About Medical University Of Vienna

The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.

Locations

Vienna, , Austria

Patients applied

0 patients applied

Trial Officials

Peter Nagele, M.D.

Principal Investigator

Medical University of Vienna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials